4
Changes in Ownership
Edgewise Therapeutics, Inc. Filed Acc 0001562180-23-005174
Options or other derivatives
- Director acquired 22,123 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Brege Laura Director | 2023-06-12 | Grant or award · Stock Option (Right to Buy) | +22,123 | 22,123 | D: show line 1 in the form |
Loading xslF345X04/primarydocument.xml…